Abstract
G protein-coupled receptors represent one of the largest families of drug targets. Time and cost may be saved if GPCR modulators are assessed in terms of signaling pathway selectivity, species selectivity, and selectivity against closely-related family members early in the drug discovery process, perhaps even at the stage of high-throughput screening. Examples are given of how these kinds of selectivity have been addressed during screening.
Keywords: β-Arrestin, desensitization, G protein-coupled receptor, selectivity, G protein, high throughput screening, receptor subtype, species, Arrestin, 2-adrenergic receptor, (hydroxyphenylorciprenaline), GPCR signaling, MAPKs, angiotensin II receptor type 1, parathy-roid hormone receptor, protease activated receptor, vasopressin 2 receptor, herkinorin, Ligand Pharmaceutical's Encoded Combinatorial Librar-ies on Polymeric Support, bradykinin receptor 1, melano-cortin (MC)-4 receptor (MC4R)
Current Pharmaceutical Biotechnology
Title: Pathway-Specific, Species, and Sub-Type Counterscreening for Better GPCR Hits in High Throughput Screening
Volume: 11 Issue: 7
Author(s): Robert Swanson and James R. Beasley
Affiliation:
Keywords: β-Arrestin, desensitization, G protein-coupled receptor, selectivity, G protein, high throughput screening, receptor subtype, species, Arrestin, 2-adrenergic receptor, (hydroxyphenylorciprenaline), GPCR signaling, MAPKs, angiotensin II receptor type 1, parathy-roid hormone receptor, protease activated receptor, vasopressin 2 receptor, herkinorin, Ligand Pharmaceutical's Encoded Combinatorial Librar-ies on Polymeric Support, bradykinin receptor 1, melano-cortin (MC)-4 receptor (MC4R)
Abstract: G protein-coupled receptors represent one of the largest families of drug targets. Time and cost may be saved if GPCR modulators are assessed in terms of signaling pathway selectivity, species selectivity, and selectivity against closely-related family members early in the drug discovery process, perhaps even at the stage of high-throughput screening. Examples are given of how these kinds of selectivity have been addressed during screening.
Export Options
About this article
Cite this article as:
Swanson Robert and R. Beasley James, Pathway-Specific, Species, and Sub-Type Counterscreening for Better GPCR Hits in High Throughput Screening, Current Pharmaceutical Biotechnology 2010; 11 (7) . https://dx.doi.org/10.2174/138920110792927775
DOI https://dx.doi.org/10.2174/138920110792927775 |
Print ISSN 1389-2010 |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-4316 |
Call for Papers in Thematic Issues
Artificial Intelligence in Bioinformatics
Bioinformatics is an interdisciplinary field that analyzes and explores biological data. This field combines biology and information system. Artificial Intelligence (AI) has attracted great attention as it tries to replicate human intelligence. It has become common technology for analyzing and solving complex data and problems and encompasses sub-fields of machine ...read more
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Evaluation Approach can Significantly Influence Oral Glucose-Lowering Drugs Total Mortality Risks in Retrospective Cohorts of Type 2 Diabetes Mellitus Patients
Current Diabetes Reviews Recent Advancement and Technological Aspects of Pulsatile Drug Delivery System - A Laconic Review
Current Drug Targets Parathyroid Hormone and Heart Failure: Novel Biomarker Strategy
Endocrine, Metabolic & Immune Disorders - Drug Targets Development of New H1 Antihistamines: The Importance of Pharmacokinetics in the Evaluation of Safe and Therapeutically Effective Agents
Current Medicinal Chemistry - Anti-Inflammatory & Anti-Allergy Agents Current Pharmacologic Management of Pediatric Heart Failure in Congenital Heart Disease
Current Vascular Pharmacology Editorial: Recent News on Statins for the Treatment of Non-Alcoholic Fatty Liver Disease/Non-Alcoholic Steatohepatitis
Current Vascular Pharmacology Fc-independent Phagocytosis: Implications for IVIG and other Therapies in Immune-mediated Thrombocytopenia
Cardiovascular & Hematological Disorders-Drug Targets Mineralocorticoid Receptor Blockade in the Protection of Target Organ Damage
Cardiovascular & Hematological Agents in Medicinal Chemistry Antimicrobial Agents-Associated with QT Interval Prolongation
Current Drug Safety A Mini-Review on Cardiovascular and Hematological Complications of COVID-19
Coronaviruses Microvascular Alterations in Hypertension and Vascular Aging
Current Hypertension Reviews Electronegative LDL: An Active Player in Atherogenesis or a By- Product of Atherosclerosis?
Current Medicinal Chemistry Oxidative Stress Drivers and Modulators in Obesity and Cardiovascular Disease: From Biomarkers to Therapeutic Approach
Current Medicinal Chemistry Metabolic Features Across the Female Life Span in Women with PCOS
Current Pharmaceutical Design Serpin Regulation of Fibrinolytic System: Implications for Therapeutic Applications in Cardiovascular Diseases
Cardiovascular & Hematological Agents in Medicinal Chemistry Heat Shock Protein (HSP) Drug Discovery and Development: Targeting Heat Shock Proteins in Disease
Current Topics in Medicinal Chemistry Tryptophan Catabolites and Their Impact on Multiple Sclerosis Progression
Current Pharmaceutical Design Reversal of Informational Entropy and the Acquisition of Germ-like Immortality by Somatic Cells
Current Aging Science Cellular Signaling Crosstalk Between Multiple Receptors for Investigation of Pathophysiology in Multifactorial Diseases - What is Clinically-Relevant Crosstalk?
Current Medicinal Chemistry P2Y Receptor Activation Affects the Proliferation and Differentiation of Glial and Neuronal Cells: A Focus on Rat C6 Glioma Cells
Current Neuropharmacology